Memorial Sloan Kettering executives' financial ties to industry part of culture problem, report finds

On Thursday, MSK announced new policies governing employees' financial relationships with outside companies, Propublica and the Times reported. (Memorial Sloan Kettering)

Officials at Memorial Sloan Kettering fostered a culture where profits were more important than patient care and research, a new external report on conflicts of interest at the institution found. 

Reported by the New York Times and ProPublica, an external review conducted by the law firm Debevoise & Plimpton examining executives’ ties to drug and health care companies concluded those officials frequently violated or skirted policies at the cancer center.

Researchers conducting studies were often unaware of the connected financial stakes held by leadership, the report said.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

RELATED: Fall from grace: Questions about prominent researchers raise bigger questions about ethics in medicine

On Thursday, MSK announced new policies governing employees' financial relationships with outside companies, ProPublica and the Times reported

Suggested Articles

Memorial Sloan Kettering Cancer Center has tapped former CVS Health and Aetna executive Claus Torp Jensen, Ph.D., as its first chief digital officer.

NYC Health + Hospitals plans to upgrade millions of imaging technologies across the health system as part of a $224 million deal with GE Healthcare.

Virtual primary care is a new way to deliver healthcare.